A Randomised, Double-Blind, Phase III Efficacy and Safet

  • Cooley, Sarah A (PI)

Project: Research project

Project Details

Description

A Randomised, Double-Blind, Phase III Efficacy and Safety Study of Cediranib (RECENTIN) when Added to Cisplatin plus a Fluoropyrimidine, Compared with Cisplatin plus a Fluoropyrimidine alone, in Patients with Previously Untreated, Locally Advanced or Met
StatusFinished
Effective start/end date3/31/1012/31/12

Funding

  • AstraZeneca

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.